Jane Street Group, LLC Innoviva, Inc. Put Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	BUY	$15.39 - $20.25 $30,780 - $40,500	2,000 Added 17.54%	13,400 $259,000
Q4 2021 Feb 15, 2022	SELL	$15.91 - $18.72 $74,777 - $87,984	-4,700 Reduced 29.19%	11,400 $197,000
Q3 2021 Nov 16, 2021	SELL	$13.06 - $17.24 $28,732 - $37,928	-2,200 Reduced 12.02%	16,100 $269,000
Q1 2021 May 18, 2021	BUY	$11.06 - $12.87 $202,398 - $235,521	18,300 New	18,300 $219,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.